AKT1 and dry eye syndrome: PI3K inhibition by its antagonist LY294002 or AMPK activation by its agonist AICAR inhibited AKT activation, and subsequently, inhibited ROS production in KCs, leading to ultimately reduced APAP-induced liver injury in the hyperglycemic mice.